Professor Yoon Seung-gyu Reappointed as Director of Seoul St. Mary's Hospital... Also Serving as Director of Yeouido St. Mary's Hospital

Catholic University Seoul St. Mary's Hospital announced on the 28th that "Professor Yoon Seung-gyu (64, pictured), head of the Department of Gastroenterology and currently serving as the directors of both Seoul St. Mary's Hospital and Yeouido St. Mary's Hospital, has been reappointed as the director of both hospitals." The term of office is two years, from September 1, 2023, to August 31, 2025.

Director Yoon Seung-gyu graduated from the Catholic University College of Medicine in 1985 and earned his master's and doctoral degrees from the same graduate school. He is an authority in the fields of hepatitis and liver cancer and is renowned as a researcher integrating clinical and basic sciences. He has served as the director of the Cancer Hospital at Seoul St. Mary's Hospital, chairman of the Health and Medical Technology Promotion Project, and medical advisor for KBS. Since 2021, he has concurrently held the director positions at both Seoul St. Mary's Hospital and Yeouido St. Mary's Hospital, and has now been reappointed to both.

Upon his appointment two years ago, Director Yoon adopted the management slogan "A hospital that gives new hope through personalized medicine" and worked to realize this by "establishing an innovative medical system leading future changes." As a result, the hospital has solidified its position as an internationally safe medical institution prioritizing patients' health, safety, and happiness, and as a leading medical institution not only in Korea but globally. The hospital has succeeded in obtaining JCI accreditation five consecutive times, recognizing its compliance with international standards for safe medical services and international medical quality indicators. It has continuously achieved the highest grade in all categories of the Ministry of Health and Welfare's medical quality evaluation, ranked first for seven consecutive years in the Korean Service Quality Index for tertiary general hospitals, was selected as a world-best hospital in multiple clinical fields including cancer by the American news magazine Newsweek, and received the CEO Award for contributions to the development of Korea's service industry.

In the clinical field, the Hematology Hospital, which marked the 40th anniversary of the first successful allogeneic hematopoietic stem cell transplantation in Korea, achieved the milestone of 10,000 hematopoietic stem cell transplants?the first in the country. Not content with conventional standard treatments for hematologic diseases, the hospital maintains competitiveness in the field by advancing high-level hematopoietic stem cell transplantation, actively implementing CAR-T therapy, and leading world-class research and development.

In research, the hospital was the first university hospital in Korea to receive approval in all three detailed areas of the Advanced Regenerative Bio Act?‘Advanced Regenerative Medical Institution,’ ‘Cell Processing Facility,’ and ‘Human Cell Management Business’?removing restrictions on advanced regenerative medical research and laying the foundation for the activation of clinical research.

This content was produced with the assistance of AI translation services.